↓ Skip to main content

Modelling drug-related morbidity in Sweden using an expert panel of pharmacists’

Overview of attention for article published in International Journal of Clinical Pharmacy, April 2012
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
33 Mendeley
Title
Modelling drug-related morbidity in Sweden using an expert panel of pharmacists’
Published in
International Journal of Clinical Pharmacy, April 2012
DOI 10.1007/s11096-012-9641-3
Pubmed ID
Authors

Hanna Gyllensten, Katja M. Hakkarainen, Anna K. Jönsson, Karolina Andersson Sundell, Staffan Hägg, Clas Rehnberg, Anders Carlsten

Abstract

Drug-related morbidity (DRM) is common and to some extent preventable, and associated with considerable costs in patients attending hospital. In outpatients and in the general public corresponding data are limited, but pharmacists' expert opinion has suggested high rates of DRM also in US ambulatory care. It is unknown if the results are applicable in Sweden today.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Switzerland 1 3%
Brazil 1 3%
United States 1 3%
Bangladesh 1 3%
Unknown 29 88%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 24%
Student > Postgraduate 6 18%
Researcher 5 15%
Other 4 12%
Unspecified 3 9%
Other 7 21%
Readers by discipline Count As %
Medicine and Dentistry 13 39%
Pharmacology, Toxicology and Pharmaceutical Science 8 24%
Unspecified 4 12%
Computer Science 2 6%
Nursing and Health Professions 2 6%
Other 4 12%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 May 2012.
All research outputs
#4,212,783
of 5,041,086 outputs
Outputs from International Journal of Clinical Pharmacy
#286
of 324 outputs
Outputs of similar age
#64,576
of 78,053 outputs
Outputs of similar age from International Journal of Clinical Pharmacy
#18
of 21 outputs
Altmetric has tracked 5,041,086 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 324 research outputs from this source. They receive a mean Attention Score of 2.6. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 78,053 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.